Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

News from AACR: Abbott researchers report findings on farnesyltransferase inhibitors

April 15, 1999

Profile of ZD-4190, a potent VEGF receptor tyrosine kinase inhibitor and antiangiogenic agent

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

Novel water-soluble camptothecin analogue suitable for formulation in liposomes

April 15, 1999

Sugen presents preclinical data for SU-6668 at AACR meeting

April 15, 1999

PEG-rMETase, a promising new approach to cancer therapy

April 15, 1999

Potent and specific FTase inhibitor presented by Biomeasure

April 15, 1999

Merck presents protein farnesyltransferase inhibitor in phase I testing

April 15, 1999

Substituted purines and pyrimidines as inhibitors of cyclin-dependent kinases

April 14, 1999

Farnesyltransferase inhibitors especially effective in combination with other chemotherapeutic drugs

April 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...